Biomedical Engineering Reference
In-Depth Information
232
Bjornerud , A. and Johansson , L. ( 2004 )
The utility of superparamagnetic
contrast agents in MRI: theoretical
consideration and applications in the
cardiovascular system.
NMR in
Biomedicine
,
17
( 7 ), 465 - 77 .
233
Simonsen , C.Z. , Ostergaard , L. ,
Vestergaard - Poulsen , P. , Rohl , L. ,
Bjornerud , A. and Gyldensted , C. ( 1999 )
CBF and CBV measurements by USPIO
bolus tracking: reproducibility and
comparison with Gd - based values .
Journal of Magnetic Resonance Imaging
,
9
( 2 ), 342 - 7 .
234
Stillman , A.E. , Wilke , N. and Jerosch -
Herold , M. ( 1997 ) Use of an
intravascular T1 contrast agent to
improve MR cine myocardial- blood pool
defi nition in men.
Journal of Magnetic
Resonance Imaging
,
7
( 4 ), 765 - 7 .
235
Stillman , A.E. , Wilke , N. , Li , D.B. ,
Haacke , E.M. and McLachlan , S. ( 1996 )
Ultrasmall superparamagnetic iron oxide
to enhance MRA of the renal and
coronary arteries: studies in human
patients .
Journal of Computer- Assisted
Tomography
,
20
( 1 ), 51 - 5 .
236
Mayo - Smith , W.W. , Saini , S. , Slater , G. ,
Kaufman , J.A. , Sharma , P. and Hahn ,
P.F. ( 1996 ) NIR contrast material for
vascular enhancement: value of
superparamagnetic iron oxide.
American
Journal of Roentgenology
,
166
( 1 ), 73 - 7 .
237
Reimer , P. , Bremer , C. , Allkemper , T. ,
Engelhardt , M. , Mahler , M. , Ebert , W.
and Tombach , B. ( 2004 ) Myocardial
perfusion and MR angiography of chest
with SHU555C: results of placebo
controlled clinical phase I study.
Radiology
,
231
( 2 ), 474 - 81 .
238
Smith , B.R. , Heverhagen , J. , Knopp , M. ,
Schmalbrock , P. , Shapiro , J. , Shiomi , M. ,
Moldovan , N.I. , Ferrari , M. and Lee , S.C.
( 2007 ) Localization to atherosclerotic
plaque and biodistribution of
biochemically derivatized
superparamagnetic iron oxide
nanoparticles (SPIONs) contrast particles
for magnetic resonance imaging (MRI).
Biomedical Microdevices
,
9
( 5 ), 719 - 27 .
239
Kooi , M.E. , Cappendijk , V.C. , Cleutjens ,
K. , Kessels , A.G.H. , Kitslaar , P. , Borgers ,
M. , Frederik , P.M. , Daemen , M. and van
Engelshoven , J.M.A. ( 2003 )
Accumulation of ultrasmall
superparamagnetic particles of iron
oxide in human atherosclerotic plaques
can be detected by in vivo magnetic
resonance imaging.
Circulation
,
107
( 19 ),
2453 - 8 .
240
Howarth , S. , Im , J.U.K. , Trivedi , R. ,
Graves , M.J. , Brown , A. , Kirkpatrick , P.J.
and Gillard , J.H. ( 2006 ) Noninvasive
determination of macrophage burden in
asymptomatic carotid atheroma: a
USPIO enhanced MR imaging study.
Stroke
,
37
( 2 ), 650 .
241
Trivedi , R.A. , U - King - Im , J.M. , Graves ,
M.J. , Cross , J.J. , Horsley , J. , Goddard ,
M.J. , Skepper , J.N. , Quartey , G. ,
Warburton , E. , Joubert , I. , Wang , L.Q. ,
Kirkpatrick , P.J. , Brown , J. and Gillard ,
J.H. ( 2004 ) In vivo detection of
macrophages in human carotid
atheroma - temporal dependence of
ultrasmall superparamagnetic particles
of iron oxide-enhanced MRI.
Stroke
,
35
( 7 ), 1631 - 5 .
242
Rogers , W.J. , Meyer , C.H. and Kramer ,
C.M. ( 2006 ) Technology insight: in vivo
cell tracking by use of MRI.
Nature
Clinical Practice. Cardiovascular Medicine
,
3
( 10 ), 554 - 62 .
243
Frank , J.A. , Anderson , S.A. , Kalsih , H. ,
Jordan , E.K. , Lewis , B.K. , Yocum , G.T.
and Arbab , A.S. ( 2004 ) Methods for
magnetically labeling stem and other
cells for detection by in vivo magnetic
resonance imaging.
Cytotherapy
,
6
( 6 ),
621 - 5 .
244
Bulte , J.W.M. and Kraitchman , D.L.
(2004) Monitoring cell therapy using
iron oxide MR contrast agents.
Current
Pharmaceutical Biotechnology
,
5
( 6 ),
567 - 84 .
245
Heyn , C. , Ronald , J.A. , Mackenzie , L.T. ,
MacDonald , I.C. , Chambers , A.F. , Rutt ,
B.K. and Foster , P.J. ( 2006 ) In vivo
magnetic resonance imaging of single
cells in mouse brain with optical
validation.
Magnetic Resonance in
Medicine
,
55
( 1 ), 23 - 9 .
246
Rogers , W.J. and Basu , P. ( 2005 )
Factors regulating macrophage
endocytosis of nanoparticles:
implications for targeted magnetic
